Regulus Therapeutics to Present at the Oppenheimer 35th Annual Healthcare Life Sciences Conference

Rhea-AI Summary

Regulus Therapeutics (Nasdaq: RGLS), a biopharmaceutical company specializing in microRNA-targeted medicine development, has announced its participation in the Oppenheimer 35th Annual Healthcare Life Sciences Conference. The company's management team will engage in a fireside chat scheduled for Tuesday, February 11th at 2:40 p.m. ET.

Investors and interested parties can access both the live event and replay through the investor relations section of Regulus' website at https://ir.regulusrx.com/events. The presentation recording will remain accessible for 90 days following the event.

SAN DIEGO, Feb. 4, 2025 /PRNewswire/ -- Regulus Therapeutics Inc. (Nasdaq: RGLS), a biopharmaceutical company focused on the discovery and development of innovative medicines targeting microRNAs (the "Company" or "Regulus"), today announced that members of the management team will participate in a fireside chat at the Oppenheimer 35th Annual Healthcare Life Sciences Conference on Tuesday, February 11^th at 2:40 p.m. ET.

The live event and replay of the presentation will be available under "Events and Presentations" through the investor relations section of the Company's website at https://ir.regulusrx.com/events and archived for 90 days following the presentation date.

About Regulus
Regulus Therapeutics Inc. (Nasdaq: RGLS) is a biopharmaceutical company focused on the discovery and development of innovative medicines targeting microRNAs. Regulus has leveraged its oligonucleotide drug discovery and development expertise to develop a pipeline complemented by a rich intellectual property estate in the microRNA field. Regulus maintains its corporate headquarters in San Diego, CA.

View original content to download multimedia:https://www.prnewswire.com/news-releases/regulus-therapeutics-to-present-at-the-oppenheimer-35th-annual-healthcare-life-sciences-conference-302366886.html

SOURCE Regulus Therapeutics Inc.

FAQ

When is Regulus Therapeutics (RGLS) presenting at the Oppenheimer Healthcare Conference?

Regulus Therapeutics will present at the Oppenheimer Healthcare Conference on Tuesday, February 11th at 2:40 p.m. ET.

How long will the RGLS Oppenheimer Conference presentation replay be available?

The presentation replay will be available for 90 days following the presentation date through Regulus' investor relations website.

Where can investors watch Regulus Therapeutics' (RGLS) Oppenheimer Conference presentation?

Investors can watch the presentation live or access the replay through Regulus' investor relations website at https://ir.regulusrx.com/events.

What type of presentation will RGLS give at the Oppenheimer Healthcare Conference?

Regulus Therapeutics will participate in a fireside chat format presentation at the conference.